annual FCF:
$178.75M+$39.27M(+28.15%)Summary
- As of today (June 17, 2025), PCRX annual free cash flow is $178.75 million, with the most recent change of +$39.27 million (+28.15%) on December 31, 2024.
- During the last 3 years, PCRX annual FCF has risen by +$98.90 million (+123.86%).
- PCRX annual FCF is now at all-time high.
Performance
PCRX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$26.91M-$4.10M(-13.23%)Summary
- As of today (June 17, 2025), PCRX quarterly free cash flow is $26.91 million, with the most recent change of -$4.10 million (-13.23%) on March 31, 2025.
- Over the past year, PCRX quarterly FCF has dropped by -$19.35 million (-41.83%).
- PCRX quarterly FCF is now -47.89% below its all-time high of $51.65 million, reached on June 30, 2024.
Performance
PCRX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$159.40M-$19.35M(-10.83%)Summary
- As of today (June 17, 2025), PCRX TTM free cash flow is $159.40 million, with the most recent change of -$19.35 million (-10.83%) on March 31, 2025.
- Over the past year, PCRX TTM FCF has dropped by -$13.79 million (-7.96%).
- PCRX TTM FCF is now -17.63% below its all-time high of $193.53 million, reached on September 30, 2024.
Performance
PCRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
PCRX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.1% | -41.8% | -8.0% |
| 3 y3 years | +123.9% | +16.4% | +53.3% |
| 5 y5 years | +196.1% | +5315.3% | +173.1% |
PCRX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.9% | -47.9% | +114.2% | -17.6% | +72.0% |
| 5 y | 5-year | at high | +355.6% | -47.9% | +209.7% | -17.6% | +1114.7% |
| alltime | all time | at high | +302.2% | -47.9% | +203.9% | -17.6% | +280.3% |
PCRX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $26.91M(-13.2%) | $159.40M(-10.8%) |
| Dec 2024 | $178.75M(+28.1%) | $31.01M(-37.8%) | $178.75M(-7.6%) |
| Sep 2024 | - | $49.83M(-3.5%) | $193.53M(+4.8%) |
| Jun 2024 | - | $51.65M(+11.6%) | $184.74M(+6.7%) |
| Mar 2024 | - | $46.27M(+1.0%) | $173.19M(+24.2%) |
| Dec 2023 | $139.49M(+21.1%) | $45.79M(+11.6%) | $139.49M(+7.1%) |
| Sep 2023 | - | $41.04M(+2.4%) | $130.25M(+2.8%) |
| Jun 2023 | - | $40.09M(+219.2%) | $126.68M(+21.0%) |
| Mar 2023 | - | $12.56M(-65.6%) | $104.65M(-9.2%) |
| Dec 2022 | $115.20M(+44.3%) | $36.55M(-2.5%) | $115.20M(+24.3%) |
| Sep 2022 | - | $37.47M(+107.4%) | $92.70M(-9.5%) |
| Jun 2022 | - | $18.07M(-21.8%) | $102.44M(-1.5%) |
| Mar 2022 | - | $23.11M(+64.5%) | $103.95M(+30.2%) |
| Dec 2021 | $79.85M(+103.5%) | $14.05M(-70.2%) | $79.85M(-18.6%) |
| Sep 2021 | - | $47.21M(+141.1%) | $98.06M(+18.3%) |
| Jun 2021 | - | $19.58M(-2074.1%) | $82.87M(+113.8%) |
| Mar 2021 | - | -$992.00K(-103.1%) | $38.76M(-1.2%) |
| Dec 2020 | $39.23M(-35.0%) | $32.26M(+0.8%) | $39.23M(+38.2%) |
| Sep 2020 | - | $32.02M(-230.5%) | $28.38M(+116.3%) |
| Jun 2020 | - | -$24.53M(+4653.9%) | $13.12M(-77.5%) |
| Mar 2020 | - | -$516.00K(-102.4%) | $58.36M(-3.3%) |
| Dec 2019 | $60.36M(+75.7%) | $21.41M(+27.7%) | $60.36M(+4.2%) |
| Sep 2019 | - | $16.76M(-19.1%) | $57.93M(+8.6%) |
| Jun 2019 | - | $20.71M(+1298.4%) | $53.34M(+22.0%) |
| Mar 2019 | - | $1.48M(-92.2%) | $43.71M(+27.2%) |
| Dec 2018 | $34.36M(-2419.8%) | $18.98M(+55.9%) | $34.36M(+26.2%) |
| Sep 2018 | - | $12.18M(+9.9%) | $27.23M(+298.7%) |
| Jun 2018 | - | $11.08M(-240.7%) | $6.83M(-218.9%) |
| Mar 2018 | - | -$7.87M(-166.4%) | -$5.74M(+287.8%) |
| Dec 2017 | -$1.48M | $11.86M(-244.1%) | -$1.48M(+70.4%) |
| Sep 2017 | - | -$8.23M(+448.8%) | -$869.00K(-105.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$1.50M(-58.5%) | $15.14M(-1.1%) |
| Mar 2017 | - | -$3.61M(-129.0%) | $15.31M(+75.1%) |
| Dec 2016 | $8.74M(-171.2%) | $12.47M(+60.3%) | $8.74M(+108.8%) |
| Sep 2016 | - | $7.78M(-686.1%) | $4.19M(-140.4%) |
| Jun 2016 | - | -$1.33M(-87.0%) | -$10.38M(-24.3%) |
| Mar 2016 | - | -$10.17M(-228.6%) | -$13.70M(+11.7%) |
| Dec 2015 | -$12.27M(-442.8%) | $7.91M(-216.6%) | -$12.27M(-14.1%) |
| Sep 2015 | - | -$6.79M(+45.8%) | -$14.29M(+311.8%) |
| Jun 2015 | - | -$4.65M(-46.8%) | -$3.47M(-202.6%) |
| Mar 2015 | - | -$8.74M(-248.2%) | $3.38M(-5.6%) |
| Dec 2014 | $3.58M(-106.4%) | $5.90M(+46.4%) | $3.58M(-129.8%) |
| Sep 2014 | - | $4.03M(+83.6%) | -$12.03M(-60.7%) |
| Jun 2014 | - | $2.19M(-125.7%) | -$30.59M(-36.1%) |
| Mar 2014 | - | -$8.54M(-12.0%) | -$47.83M(-14.6%) |
| Dec 2013 | -$56.01M(-36.6%) | -$9.71M(-33.2%) | -$56.01M(-22.4%) |
| Sep 2013 | - | -$14.53M(-3.4%) | -$72.22M(-3.9%) |
| Jun 2013 | - | -$15.05M(-10.0%) | -$75.12M(-11.3%) |
| Mar 2013 | - | -$16.72M(-35.5%) | -$84.66M(-4.2%) |
| Dec 2012 | -$88.39M(+137.8%) | -$25.91M(+48.6%) | -$88.39M(+21.8%) |
| Sep 2012 | - | -$17.43M(-29.1%) | -$72.56M(+11.2%) |
| Jun 2012 | - | -$24.59M(+20.3%) | -$65.26M(+23.6%) |
| Mar 2012 | - | -$20.45M(+102.9%) | -$52.79M(+42.0%) |
| Dec 2011 | -$37.17M(+17.4%) | -$10.08M(-0.6%) | -$37.17M(+3.6%) |
| Sep 2011 | - | -$10.14M(-16.4%) | -$35.88M(+3.9%) |
| Jun 2011 | - | -$12.13M(+151.6%) | -$34.55M(+6.4%) |
| Mar 2011 | - | -$4.82M(-45.2%) | -$32.46M(+2.5%) |
| Dec 2010 | -$31.65M(+20.1%) | -$8.79M(-0.3%) | -$31.65M(+38.4%) |
| Sep 2010 | - | -$8.81M(-12.2%) | -$22.86M(+62.7%) |
| Jun 2010 | - | -$10.04M(+150.1%) | -$14.05M(+250.1%) |
| Mar 2010 | - | -$4.01M | -$4.01M |
| Dec 2009 | -$26.35M(-24.8%) | - | - |
| Dec 2008 | -$35.03M | - | - |
FAQ
- What is Pacira BioSciences annual free cash flow?
- What is the all time high annual FCF for Pacira BioSciences?
- What is Pacira BioSciences annual FCF year-on-year change?
- What is Pacira BioSciences quarterly free cash flow?
- What is the all time high quarterly FCF for Pacira BioSciences?
- What is Pacira BioSciences quarterly FCF year-on-year change?
- What is Pacira BioSciences TTM free cash flow?
- What is the all time high TTM FCF for Pacira BioSciences?
- What is Pacira BioSciences TTM FCF year-on-year change?
What is Pacira BioSciences annual free cash flow?
The current annual FCF of PCRX is $178.75M
What is the all time high annual FCF for Pacira BioSciences?
Pacira BioSciences all-time high annual free cash flow is $178.75M
What is Pacira BioSciences annual FCF year-on-year change?
Over the past year, PCRX annual free cash flow has changed by +$39.27M (+28.15%)
What is Pacira BioSciences quarterly free cash flow?
The current quarterly FCF of PCRX is $26.91M
What is the all time high quarterly FCF for Pacira BioSciences?
Pacira BioSciences all-time high quarterly free cash flow is $51.65M
What is Pacira BioSciences quarterly FCF year-on-year change?
Over the past year, PCRX quarterly free cash flow has changed by -$19.35M (-41.83%)
What is Pacira BioSciences TTM free cash flow?
The current TTM FCF of PCRX is $159.40M
What is the all time high TTM FCF for Pacira BioSciences?
Pacira BioSciences all-time high TTM free cash flow is $193.53M
What is Pacira BioSciences TTM FCF year-on-year change?
Over the past year, PCRX TTM free cash flow has changed by -$13.79M (-7.96%)